tiprankstipranks
Advertisement
Advertisement
Analyst Maintains Hold on Inspire as Reimbursement Uncertainty Persists; $53 Price Target Reaffirmed
PremiumRatingsAnalyst Maintains Hold on Inspire as Reimbursement Uncertainty Persists; $53 Price Target Reaffirmed
10d ago
Nyxoah downgraded to Hold from Buy at Stifel
Premium
The Fly
Nyxoah downgraded to Hold from Buy at Stifel
16d ago
Oppenheimer sees new MAC billing change as fresh headache for Inspire Medical
Premium
The Fly
Oppenheimer sees new MAC billing change as fresh headache for Inspire Medical
20d ago
Roblox downgraded, Chipotle upgraded: Wall Street’s top analyst calls
PremiumThe FlyRoblox downgraded, Chipotle upgraded: Wall Street’s top analyst calls
22d ago
Inspire Medical price target lowered to $54 from $67 at JPMorgan
Premium
The Fly
Inspire Medical price target lowered to $54 from $67 at JPMorgan
22d ago
Inspire Medical price target lowered to $55 from $62 at Evercore ISI
Premium
The Fly
Inspire Medical price target lowered to $55 from $62 at Evercore ISI
22d ago
Inspire Medical price target lowered to $50 from $63 at Baird
PremiumThe FlyInspire Medical price target lowered to $50 from $63 at Baird
22d ago
Inspire Medical downgraded at BofA on cloudy path back to growth
Premium
The Fly
Inspire Medical downgraded at BofA on cloudy path back to growth
22d ago
Inspire Medical downgraded to Neutral from Buy at BofA
Premium
The Fly
Inspire Medical downgraded to Neutral from Buy at BofA
22d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100